Dorrapharma is engaged in R&D, manufacture and market of intermediates, APIs (Active Pharmaceutical Ingredients) and formulations. We own the core technologyadvantage in the professional area of bromination,enzyme/metal-catalyzed, nitration and hydrogenation, and obtain multiple core patents for invention.We stick to raising the value both for the company and customers, and strive creating more valuable product for the health of the life...
MOREIn recent years, Dorra’s business type has expanded and business scale...
February 0, 2023 -- Today, the U.S. Food and Drug Administration approved Jesduvroq tablet...
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1